Stage 4 Ovarian Cancer Treatment in Ahmedabad — Dr. Nishtha Tripathi Patel is an ESGO-certified gynaecological oncosurgeon offering specialist treatment for stage 4 ovarian cancer treatment at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital in Ahmedabad.
On this page
- What this stage means
- Recommended treatment pathway
- Adjuvant therapy
- Outlook and survival data
- Booking
- FAQs
What does this stage mean?
Stage 4 ovarian cancer has spread to distant organs (lungs, liver parenchyma, distant lymph nodes) or has malignant pleural effusion. Treatment is individualised: neoadjuvant chemotherapy is usually used, followed by interval cytoreductive surgery if response is good. HIPEC may be considered in selected cases with isolated peritoneal Stage 4A disease.
For broader information see our cancer overview and treatment page.
Recommended treatment pathway
Stage 4 ovarian cancer has spread to distant organs (lungs, liver parenchyma, distant lymph nodes) or has malignant pleural effusion. Treatment is individualised: neoadjuvant chemotherapy is usually used, followed by interval cytoreductive surgery if response is good. HIPEC may be considered in selected cases with isolated peritoneal Stage 4A disease.
Adjuvant therapy
Platinum-based chemotherapy is the backbone. Bevacizumab maintenance and PARP inhibitor maintenance (for BRCA-mutated or HRD-positive disease) significantly extend remission.
Outlook
Median overall survival 2-3 years; selected patients with BRCA mutations and complete response to platinum can have markedly longer survival on PARP maintenance.
External authoritative reference: NCCN Guidelines and ESGO Recommendations.
Booking
For an individualised treatment plan, share your reports on WhatsApp (+91 76988 00333) or book an appointment. Second opinions are available for patients already under care elsewhere.
FAQs
Where is stage 4 ovarian cancer treatment performed in Ahmedabad?
Dr. Nishtha Tripathi Patel treats this disease stage at Sterling Hospitals (Sindhubhavan), KD Hospital, and Welcare Speciality Hospital in Ahmedabad. The hospital is chosen based on the specific procedure needed and patient preference.
What is the typical hospital stay?
For minimally invasive surgery (robotic or laparoscopic), hospital stay is typically 3-4 days. For cytoreductive surgery or HIPEC, stay extends to 7-10 days. Chemoradiation is outpatient over 5-7 weeks.
What is the likely outcome?
Median overall survival 2-3 years; selected patients with BRCA mutations and complete response to platinum can have markedly longer survival on PARP maintenance. Outcomes are stage-dependent and individual; the figures above are averages from published series.
Is fertility preservation possible?
Fertility preservation is not standard for this stage. Egg or embryo cryopreservation may be considered before chemotherapy if applicable.
Can I get a second opinion before deciding?
Yes. Share your reports on WhatsApp (+91 76988 00333). Dr. Nishtha provides independent review of stage, pathology, imaging and proposed treatment within 24-48 hours.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified.